These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 31431371)

  • 21. Accelerated Hypofractionated Radiotherapy Versus Stereotactic Body Radiotherapy for the Treatment of Stage I Nonsmall Cell Lung Cancer-A Single Institution Experience With Long-Term Follow-Up.
    Karasawa K; Hayakawa S; Machitori Y; Shibata Y; Ogawa H; Ito K; Shimizuguchi T; Kawamoto T; Nihei K
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818806318. PubMed ID: 30317929
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alpha/beta ratio for normal lung tissue as estimated from lung cancer patients treated with stereotactic body and conventionally fractionated radiation therapy.
    Scheenstra AE; Rossi MM; Belderbos JS; Damen EM; Lebesque JV; Sonke JJ
    Int J Radiat Oncol Biol Phys; 2014 Jan; 88(1):224-8. PubMed ID: 24331668
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison Between Stereotactic and Conventional Radiotherapy for Solitary Lung Tumor After Resection of Lung Cancer.
    Takahashi S; Go T; Anada M; Kinoshita T; Nishide T; Yokomise H; Shibata T
    Anticancer Res; 2019 Jun; 39(6):2957-2962. PubMed ID: 31177135
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor Control Probability Analysis for Single-Fraction Carbon-Ion Radiation Therapy of Early-Stage Non-small Cell Lung Cancer.
    Paz AE; Yamamoto N; Sakama M; Matsufuji N; Kanai T
    Int J Radiat Oncol Biol Phys; 2018 Dec; 102(5):1551-1559. PubMed ID: 30076985
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of Single- and Three-fraction Schedules of Stereotactic Body Radiation Therapy for Peripheral Early-stage Non-Small-cell Lung Cancer.
    Ma SJ; Serra LM; Syed YA; Hermann GM; Gomez-Suescun JA; Singh AK
    Clin Lung Cancer; 2018 Mar; 19(2):e235-e240. PubMed ID: 29153897
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost-effectiveness analysis of stereotactic body radiotherapy and surgery for medically operable early stage non small cell lung cancer.
    Paix A; Noel G; Falcoz PE; Levy P
    Radiother Oncol; 2018 Sep; 128(3):534-540. PubMed ID: 29706462
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Universal survival curve and single fraction equivalent dose: useful tools in understanding potency of ablative radiotherapy.
    Park C; Papiez L; Zhang S; Story M; Timmerman RD
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):847-52. PubMed ID: 18262098
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlating Dose Variables with Local Tumor Control in Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer: A Modeling Study on 1500 Individual Treatments.
    Klement RJ; Sonke JJ; Allgäuer M; Andratschke N; Appold S; Belderbos J; Belka C; Blanck O; Dieckmann K; Eich HT; Mantel F; Eble M; Hope A; Grosu AL; Nevinny-Stickel M; Semrau S; Sweeney RA; Hörner-Rieber J; Werner-Wasik M; Engenhart-Cabillic R; Ye H; Grills I; Guckenberger M
    Int J Radiat Oncol Biol Phys; 2020 Jul; 107(3):579-586. PubMed ID: 32188579
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictors of Nodal and Metastatic Failure in Early Stage Non-small-cell Lung Cancer After Stereotactic Body Radiation Therapy.
    Cerra-Franco A; Liu S; Azar M; Shiue K; Freije S; Hinton J; Deig CR; Edwards D; Estabrook NC; Ellsworth SG; Huang K; Diab K; Langer MP; Zellars R; Kong FM; Wan J; Lautenschlaeger T
    Clin Lung Cancer; 2019 May; 20(3):186-193.e3. PubMed ID: 30711394
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Three- Versus Five-Fraction Regimens of Stereotactic Body Radiotherapy for Peripheral Early-Stage Non-Small-Cell Lung Cancer: A Two-Institution Propensity Score-Matched Analysis.
    Ma SJ; Cummings M; Serra LM; Syed YA; Hermann GM; Chen Y; Milano MT; Singh AK; Gomez-Suescun JA; Singh DP
    Clin Lung Cancer; 2018 May; 19(3):e297-e302. PubMed ID: 29254649
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcomes and toxicity of stereotactic body radiation therapy for advanced stage ultra-central non-small cell lung cancer.
    Cong Y; Sun B; Wang J; Meng X; Xuan L; Zhang J; Liu J; Shen G; Wu S
    Thorac Cancer; 2019 Jul; 10(7):1567-1575. PubMed ID: 31187604
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor control probability modeling for stereotactic body radiation therapy of early-stage lung cancer using multiple bio-physical models.
    Liu F; Tai A; Lee P; Biswas T; Ding GX; El Naqa I; Grimm J; Jackson A; Kong FS; LaCouture T; Loo B; Miften M; Solberg T; Li XA
    Radiother Oncol; 2017 Feb; 122(2):286-294. PubMed ID: 27871671
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improved Survival Outcomes in Medically Fit Patients With Early-Stage Non-Small-Cell Lung Cancer Undergoing Stereotactic Body Radiotherapy.
    Liu J; Hui C; Ladbury C; Waddington T; Erhunmwunsee L; Raz D; Kim J; Salgia R; Chenery S; Pearlstein D; Schwer A; Amini A
    Clin Lung Cancer; 2021 Sep; 22(5):e678-e683. PubMed ID: 33712362
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor control probability in hypofractionated radiotherapy as a function of total and hypoxic tumor volumes.
    Chvetsov AV; Hanin LG; Stewart RD; Zeng J; Rengan R; Lo SS
    Phys Med Biol; 2021 Jun; 66(12):. PubMed ID: 34030139
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Histology significantly affects recurrence and survival following SBRT for early stage non-small cell lung cancer.
    Baine MJ; Verma V; Schonewolf CA; Lin C; Simone CB
    Lung Cancer; 2018 Apr; 118():20-26. PubMed ID: 29571997
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Local control for clinical stage I non-small cell lung cancer treated with 5-fraction stereotactic body radiation therapy is not associated with treatment schedule.
    Samson P; Rehman S; Juloori A; DeWees T; Roach M; Bradley J; Videtic GMM; Stephans K; Robinson C
    Pract Radiat Oncol; 2018; 8(6):404-413. PubMed ID: 29907514
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stereotactic body radiation therapy versus sublobar resection for stage I NSCLC.
    Ackerson BG; Tong BC; Hong JC; Gu L; Chino J; Trotter JW; D'Amico TA; Torok JA; Lafata K; Chang C; Kelsey CR
    Lung Cancer; 2018 Nov; 125():185-191. PubMed ID: 30429018
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A new index comparable to BED for evaluating the biological efficacy of hypofractionated radiotherapy schemes on early stage non-small cell lung cancer: analysis of data from the literature.
    Kong C; Guo WJ; Zha WW; Zhu XZ; Huang SF; Zhang YW; Xu JH; He X
    Lung Cancer; 2014 Apr; 84(1):7-12. PubMed ID: 24548340
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stereotactic body radiation therapy versus conventional radiation therapy in patients with early stage non-small cell lung cancer: an updated retrospective study on local failure and survival rates.
    Jeppesen SS; Schytte T; Jensen HR; Brink C; Hansen O
    Acta Oncol; 2013 Oct; 52(7):1552-8. PubMed ID: 23902274
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiobiological parameters of liver and lung metastases derived from tumor control data of 3719 metastases.
    Klement RJ
    Radiother Oncol; 2017 May; 123(2):218-226. PubMed ID: 28363484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.